Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1995 | 09-1995 | 06-1995 | 03-1995 | 12-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 271,000 | N/A | N/A | N/A | N/A |
| Marketable Securities | 401,000 | N/A | N/A | N/A | N/A |
| Receivables | 787,100 | N/A | N/A | N/A | N/A |
| Inventories | 410,000 | N/A | N/A | N/A | N/A |
| TOTAL | $1,869,100 | $N/A | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| Investments And Advances | 41,800 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 27,900 | 0 | 0 | 0 | 0 |
| TOTAL | $69,700 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $3,765,700 | $N/A | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 489,200 | 0 | 0 | 0 | 0 |
| Other current liabilities | 33,500 | N/A | N/A | N/A | N/A |
| TOTAL | $839,100 | $N/A | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 238,400 | N/A | N/A | N/A | N/A |
| aiOther Non-Current Liabilities | 86,200 | 0 | 0 | 0 | 0 |
| TOTAL | $324,600 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,163,700 | $N/A | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 135,200 | N/A | N/A | N/A | N/A |
| Retained earnings | 1,987,900 | N/A | N/A | N/A | N/A |
| Other shareholders' equity | 21,100 | 0 | 0 | 0 | 0 |
| TOTAL | $2,602,000 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $3,765,700 | $0 | $0 | $0 | $0 |